1. Using pulsed dye laser to treat sebaceous hyperplasia: comparison of short and long pulse-duration pulsed dye laser
- Author
-
Sheng-Pei Wang, Ying-Jui Chang, Ching-Chi Chi, Shu-Hui Wang, and Tsung-Hua Tsai
- Subjects
long pulse-duration pulsed dye laser ,sebaceous hyperplasia ,short pulse-duration pulsed dye laser ,Dermatology ,RL1-803 - Abstract
Background: Pulsed dye laser (PDL) is effective in treating sebaceous hyperplasia (SH). However, only short pulse-duration PDL (SPDL) has been used in previous studies. Objectives: To determine whether long pulse-duration PDL (LPDL) can achieve comparable efficacy in treating SH with fewer side effects versus SPDL. Methods: Eight patients with a total of 75 SH lesions were enrolled. Each SH lesion was randomized to be treated with two sessions of 595-nm SPDL with 0.45-millisecond pulse duration or 595-nm LPDL with 20-millisecond pulse duration. The second session was performed 4 weeks after the first session. Side effects including pain and post-treatment purpura were recorded. Follow-up examinations were conducted at 1 week and 4 weeks after the first session, and at 1 week, 4 weeks, and 8 weeks after the second session for repeated photography and assessing the diameter and thickness of each lesion, post-treatment purpura, and other adverse events. Results: All SH lesions responded to two sessions of PDL treatments. The reduction ratio of lesion diameter was 76.3% in the SPDL group and 70.0% in the LPDL group after two sessions of treatments (p = 0.644). The reduction ratio of lesion thickness was 79.6% in the SPDL group and 72.7% in the LPDL group after two sessions of treatment (p = 0.187). The mean intensity of pain was 3.13 on a 0–10-point scale for SPDL and 3.60 for LPDL (p = 0.660). The intensity of immediate post-treatment purpura was 4.13 on a 0–5-point scale for SPDL, and 1.80 for LPDL (p
- Published
- 2017
- Full Text
- View/download PDF